跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
APO-MOXONIDINE moxonidine 400 microgram film-coated tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
APO-MOXONIDINE moxonidine 400 microgram film-coated tablet blister pack
Approved
STANDARD
APO-MOXONIDINE moxonidine 400 microgram film-coated tablet blister pack
Southern Cross Pharma Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
a7bf1bc5954ad1fe
Company
Southern Cross Pharma Pty Ltd
Type
Standard
Approval Details
Approval Id
a7bf1bc5954ad1fe
Product Name
APO-MOXONIDINE moxonidine 400 microgram film-coated tablet blister pack
Artg Id
285632
Artg Name
APO-MOXONIDINE moxonidine 400 microgram film-coated tablet blister pack
Sponsor
Southern Cross Pharma Pty Ltd
Company Detail Path
/organization/southern-cross-pharma-pty-ltd
Artg Date
2018-01-16
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2018-CMI-01800-1
Product Information
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2018-PI-01799-1
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
a7bf1bc5954ad1fe
Type
Standard
Back to TGA Approvals